Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Ginsana on Hemoglobin Re-oxygenation in Recreational Sportspeople
NCT02182882Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 1999
- Primary completion
- Oct 1999
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Change from baseline in half-time hemoglobin re-oxygenation by Near InfraRed Spectroscopy (NIRS) at Day 84. Started Mar 1999; status: completed.
Beyond the preview
Go deeper on NCT02182882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02182882.